封面
市場調查報告書
商品編碼
1672681

全球荷爾蒙補充療法市場按治療類型、給藥途徑、應用、分銷管道和地區分類

Hormone Replacement Therapy Market, By Therapy Type, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球荷爾蒙補充療法市場規模估計為 157.8 億美元,預計到 2032 年將達到 237.5 億美元,2025 年至 2032 年的複合年成長率為 6.0%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 157.8億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 6.00% 2032 年價值預測 237.5億美元
數字。 2025 年荷爾蒙補充療法市場佔有率(%),按地區分類
荷爾蒙替代療法市場-IMG1

由於全球女性更年期症狀的盛行率不斷上升,全球荷爾蒙補充療法市場在過去幾年中經歷了顯著成長。荷爾蒙補充療法可以幫助治療更年期後出現的許多症狀,包括潮熱、盜汗、陰道乾燥、性慾減退和情緒低落。人們對骨質疏鬆症和其他與荷爾蒙失衡和老齡化有關的慢性疾病的健康問題日益擔憂,推動了對有效治療方案的需求。此外,人們對女性健康問題的認知不斷提高以及各種荷爾蒙替代製劑的普及預計將在預測期內推動市場擴張。然而,長期使用荷爾蒙藥物的副作用以及替代治療方案的可用性等因素可能會繼續在一定程度上阻礙市場成長。

市場動態:

推動全球荷爾蒙補充療法市場發展的關鍵因素包括易患荷爾蒙缺乏症的老年人口快速增加、女性更年期症狀發病率上升、全球文明病激增以及人們對荷爾蒙補充療法在管理慢性病方面的益處的認知不斷提高。另一方面,長期使用荷爾蒙藥物所帶來的副作用,包括乳癌、心臟病、中風和血栓,對市場相關人員構成了重大挑戰。然而,持續進行的新型藥物輸送系統、各種激素組合以及生物同質激素配方創新的研究和開發預計將在未來幾年為相關人員提供豐厚的成長機會。

本研究的主要特點

  • 本報告對全球荷爾蒙補充療法市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它還強調了各個領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
  • 全球荷爾蒙補充療法市場的主要企業是根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出的。
  • 主要企業包括諾華公司、雅培公司、邁蘭公司、默克公司、拜耳公司、輝瑞公司、諾和諾德公司、QuatRx Pharmaceuticals、梯瓦製藥工業有限公司、安進公司、禮來公司、Halozyme Therapeutics 公司、艾伯維公司、Noven Pharmaceuticals 公司和 i-MAB Bioph 公司。
  • 本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球荷爾蒙補充療法市場迎合了該行業的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球荷爾蒙補充療法市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管情景
  • 製造商收益
  • 採用非侵入式感測器技術
  • 收購和合作場景
  • 產品發布/核准
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第 4 章。全球荷爾蒙補充療法市場:COVID-19 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 全球荷爾蒙補充療法市場按治療類型分類(2020-2032 年)

  • 雌激素替代療法
  • 人體生長荷爾蒙(HGH) 替代療法
  • 甲狀腺替代療法
  • 睾酮替代療法
  • 其他

6. 全球荷爾蒙補充療法市場按給藥途徑分類(2020-2032 年)

  • 口服
  • 腸外
  • 其他

7. 全球荷爾蒙補充療法市場按應用分類(2020-2032 年)

  • 甲狀腺機能低下症
  • 男性性腺功能低下症
  • 生長激素缺乏
  • 其他

8. 全球荷爾蒙補充療法市場按分銷管道分類(2020-2032 年)

  • 院內藥房
  • 零售藥局
  • 網路藥局

9. 全球荷爾蒙補充療法市場(按地區) (2020-2032)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭格局

  • 公司簡介
    • Novartis AG
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

第 11 章 分析師觀點

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第 12 章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2079

Global Hormone Replacement Therapy Market is estimated to be valued at USD 15.78 Bn in 2025 and is expected to reach USD 23.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 15.78 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.00% 2032 Value Projection: USD 23.75 Bn
Figure. Hormone Replacement Therapy Market Share (%), By Region 2025
Hormone Replacement Therapy Market - IMG1

The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics:

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation-

  • By Therapy Type:
    • Estrogen Replacement Therapy
    • Human Growth Hormone (HGH) Replacement Therapy
    • Thyroid Replacement Therapy
    • Testosterone Replacement Therapy
    • Others
  • By Route of Administration:
    • Oral
    • Parenteral
    • Others
  • By Application:
    • Hypothyroidism
    • Male Hypogonadism
    • Growth Hormone Deficiency
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Novartis AG
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Adoption of Non-invasive Sensor Technologies
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Estrogen Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Human Growth Hormone (HGH) Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thyroid Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Testosterone Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Hormone Replacement Therapy Market, By Route of Administration, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Hormone Replacement Therapy Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypothyroidism
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Male Hypogonadism
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Growth Hormone Deficiency
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Hormone Replacement Therapy Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Novartis AG*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
    • Mylan NV
    • Merck KgaA
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • Eli Lilly and Company
    • Halozyme Therapeutics, Inc.
    • AbbVie, Inc.
    • Noven Pharmaceuticals, Inc.
    • I-MAB Biopharma Co., Ltd.
    • Myovant Sciences

11. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact